A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Clinical trial NCT07018700 · RECRUITING

Trial details

NCT number: NCT07018700
Sponsor: Merz Therapeutics GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Migraine

Start date: 2025-08-21
Primary completion: 2027-03-01
Enrollment: 990

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.